We're a company founded to improve outcomes for patients with cancer.
Powerful New Oncolytic Viruses
Our team is based in state-of-the-art R&D facilities at the Hunter Medical Research Institute (HMRI) and is supported by the University of Newcastle Research Associates (TUNRA) in Newcastle, New South Wales, Australia
The ImmVirX team comprises key directors, executives and scientific staff from Viralytics.
Leveraging our leadership and experience in oncolytic viral therapies, we are actively progressing clinical trials, based on a body of pre-clinical and manufacturing data developed since operations commenced in 2020.
In the News
View our recent news stories
Discover the latest news articles featuring ImmVirX, including research innovations, stories about our people and reports from the latest events.
View All Stories